Vasorelaxant effects of eugenol on rat thoracic aorta

被引:76
作者
Damiani, CEN
Rossoni, LV
Vassallo, DV
机构
[1] CBM, UFES, Dept Ciencias Fisiol, BR-29040090 Vitoria, ES, Brazil
[2] Univ Fed Parana, Dept Physiol, Curitiba, Parana, Brazil
[3] EMESCAM, Sch Med Santa Casa Misericordia Vitoria, Vitoria, ES, Brazil
关键词
eugenol; vascular reactivity; phenylephrine; endothelium; nitric oxide; L-NAME;
D O I
10.1016/S1537-1891(02)00311-7
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Eugenol is a natural pungent substance and the main component of clove oil, with vasorelaxant action. To elucidate some of the possible mechanisms involved in this action isometric tension was measured in aortic rings from male Wistar rats precontracted with phenylephrine (PHE, 10(-7) M) or KCl (75 mM). Responses to increasing concentrations of eugenol (10(-6)-10(-2) M) were obtained in the presence and absence of endothelium. In the presence of eugenol, dose-response curves to PHE (10(-9) to 10(-4) M) and KCl (5-125 MM) were displaced downwards. Concentration-dependent relaxation was observed in rings precontracted with PHE (10(-7) M) and KCl (75 mm). The tension increment produced by increasing external calcium concentration (0.25-3 mM) was also reduced by eugenol (300 muM) treatment. The inhibitory effects of eugenol (300 muM) were compared to those induced by nifedipine (0.01 muM), a selective Ca2+ channel blocker, producing similar relaxant effects. Two other protocols were performed. After precontraction with PHE (10(-7) M), increasing concentrations of eugenol (10(-6)-10(-2) M) were used before and after N-w-nitro-L-arginine (L-NAME, 10(-4) M) and methylene blue (10(-5) M) treatment. Eugenol-induced relaxation was reduced by endothelial damage (rubbing), L-NAME and methylene blue treatments. Results suggested that eugenol produces smooth muscle relaxation resulting from the blockade of both voltage-sensitive and receptor-operated channels that are modulated by endothelial-generated nitric oxide. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 33 条
[1]
Molecular aspects of soluble guanylyl cyclase regulation [J].
Andreopoulos, S ;
Papapetropoulos, A .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (03) :147-157
[2]
CALCIUM-ACTIVATED POTASSIUM CHANNELS IN SINGLE SMOOTH-MUSCLE CELLS OF RABBIT JEJUNUM AND GUINEA-PIG MESENTERIC-ARTERY [J].
BENHAM, CD ;
BOLTON, TB ;
LANG, RJ ;
TAKEWAKI, T .
JOURNAL OF PHYSIOLOGY-LONDON, 1986, 371 :45-67
[3]
EFFECTS OF EUGENOL ON RAT PHRENIC-NERVE AND PHRENIC NERVE-DIAPHRAGM PREPARATIONS [J].
BRODIN, P ;
ROED, A .
ARCHIVES OF ORAL BIOLOGY, 1984, 29 (08) :611-615
[4]
DISSEMINATED INTRAVASCULAR COAGULATION AND HEPATOCELLULAR NECROSIS DUE TO CLOVE OIL [J].
BROWN, SA ;
BIGGERSTAFF, J ;
SAVIDGE, GF .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (05) :665-668
[5]
CALCIUM-FORCE RELATIONSHIPS AS DETECTED WITH AEQUORIN IN 2 DIFFERENT VASCULAR SMOOTH MUSCLES OF THE FERRET [J].
DEFEO, TT ;
MORGAN, KG .
JOURNAL OF PHYSIOLOGY-LONDON, 1985, 369 (DEC) :269-282
[6]
EUGENOL - ANTIPYRETIC ACTIVITY IN RABBITS [J].
FENG, J ;
LIPTON, JM .
NEUROPHARMACOLOGY, 1987, 26 (12) :1775-1778
[7]
THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE [J].
FURCHGOTT, RF ;
ZAWADZKI, JV .
NATURE, 1980, 288 (5789) :373-376
[8]
GODFRAIND T, 1986, PHARMACOL REV, V38, P321
[9]
Mechanisms of smooth muscle contraction [J].
Horowitz, A ;
Menice, CB ;
Laporte, R ;
Morgan, KG .
PHYSIOLOGICAL REVIEWS, 1996, 76 (04) :967-1003
[10]
Eugenodilol:: A third-generation β-adrenoceptor blocker, derived from eugenol, with α-adrenoceptor blocking and β2-adrenoceptor agonist-associated vasorelaxant activities [J].
Huang, YC ;
Wu, BN ;
Lin, YT ;
Chen, SJ ;
Chiu, CC ;
Cheng, CJ ;
Chen, IJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (01) :10-20